JRDC, how long have you been invested here?
What you have posted about no information is absolute tosh. For goodness sake go back and read the last few RNS's properly because your lack of knowledge is frankly embarrassing.
Well, after reflection, a positive week in my opinion with a new CEO and the likelihood that sales are good and there is plenty of news in the pipeline.
It's now time for me to devote my attention elsewhere.
Do I open a Fontodi Chianti Classico, a Sylvain Pataille Marsannay or an Oregon Pinot Noir (Willamette Valley of course) with the pasta dish tonight?
Its a bit of a no brainer frankly (as is holding on to my Novacyt shares!), its got to be the Italian wine with the Italian food!
Now, the 2015, 16 or the 17?
Endless decisions! Have a good weekend all.
Oh good God Big Yellow Pig!
You are not going to subject us to another day of your punctuation and spelling are you? I'm not sure my chuckle-muscles could stand it.
Pretty please, can you not go back to twatter? I'm sure they miss you :-)
Lewis. I have not seen anything concrete (with evidence posted) about getting results tomorrow or not. Lots of speculation only and people saying that have 'had confirmation' for both.
I therefore would not be surprised either way and anyway, we pretty much know what the rough expectations are (or at least those who have read previous RNS's and some excellent posts on here).
What does not change is the fact that this is way undervalued, has a great future and that patience is still required. Good luck all as we head into a new era.
And if we thought our volume was low.
Currency GBX
Issue Country GB
Shares in Issue 179m
Market Capitalisation £289m
Market Size 1,500
52 Week High 241.00
52 Week High Date 09-Sep-2020
52 Week Low 155.00
52 Week Low Date 04-Sep-2020
# Trades 10
Vol. Sold 1,200
Sold Value £1,932
Vol. Bought 4,550
Bought Value £7,326
PE Ratio -3.325
Earnings -48.424
Dividend 0.00
Yield 0.00%
It's an interesting thought Kitzie.
Bizarrely, Amryt Pharma have a bigger MC than us at the moment which is a bit odd given their revenue of £183m for the last year and the fact that they have a cumulative loss over the past five years of over £225m.
In fact their accounts are not pretty.
I think the least we can do is spell the new CEO's name correctly. It's Allmond not Almond (that's a nut!).
As to shorting this............brave move with where it is at the moment imo. I've scraped together enough for another 606 shares with morning by selling a dog (of a share that is, I'm not a puppy retailer!). Good lick (sic) all.